logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
E

Expert Review of Pharmacoeconomics & Outcomes Research

IF1.5
Papers65
Citations
Journal Papers 65
Publication Date
delete
Estimated cost-effectiveness of adjuvant nivolumab for resected stage IIB-IIC melanoma in the United States
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
PREAI
deleteEljilany, Islam; Diaby, Vakaramoko
deleteShare
deleteSave
Cost and clinical analysis of community-acquired pneumonia within an antimicrobial stewardship-governed academic hospital in South Africa, and its implications
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
deleteOAAI
deleteBjang, Katlego; Kutume, Madimetje; Mongoai, Nthabiseng; Sebothoma, Boitshepo; Vagiri, Rajesh; Meyer, Johanna C.; Godman, Brian; Makhele, Letlhogonolo
deleteShare
deleteSave
Antimicrobial resistance as an economic externality: optimal control, Pigouvian taxation, and governance implications
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
PREAI
deleteJana, Aritra; Khatua, Debnarayan; Mandal, Santi M.
deleteShare
deleteSave
Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off study
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
deleteOAAI
deleteRendas-Baum, Regina; Bjorner, Jakob; Preckler, Victor; Matsuki, Taizo; Ho, Yufan; Molnar, Daniel; Noto, Shinichi; Igarashi, Ataru
deleteShare
deleteSave
Analyzing the direct medical cost of schizophrenia in Hospital Pulau Pinang, Malaysia
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-05-28
delete0
PREAI
deleteAlotaibi, Fuad Fadhel; Alsuhibani, Abdulrahman A.; Ong, Siew Chin; Poh, Yih Chew; Alrasheed, Marwan A.; Alhomaidan, Ali
deleteShare
deleteSave
Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-21
delete0
deleteOAAI
deleteLasalvia, Pieralessandro; Jaramillo, Paola; Zapata, Maycos; Zapata, Martin; Gonzalez, Leonor; Hernandez, Veronica; Restrepo, Juliana
deleteShare
deleteSave
The relationship between changes in prescription drug sales and changes in mortality and hospital utilization in Denmark, 2005-2019
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-21
delete0
PREAI
deleteLichtenberg, Frank R.
deleteShare
deleteSave
Knowledge, perception and application of pharmacoeconomics among healthcare professionals in Malaysia
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-01
delete0
PREAI
deleteChandriah, Haarathi; Low, Ee Vien; Ahmad, Nur Sufiza; Ahmat, Azmi Nor Mohd Farez; Farok, Izzati Mohd; Wong, Jacqueline Hui Yi; Fun, Weng Hong; Thanimalai, Subramaniam; Ng, Chin Hui; Ibrahim, Nor Haizan; Rosli, Mohd Rozaini; Lim, Kenneth Lik Chien; Choo, Yai Wen
deleteShare
deleteSave
Burden Tree - a conceptual framework for the burden associated with pediatric infectious diseases: a Delphi approach
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-04-01
delete0
PREAI
deleteCarias, Cristina; Riley, Danielle; Eiden, Amanda L.; Enstone, Ashley L.; Whittle, Isabelle J.; Marshall, Deanna B.; Oswald, Charlotte W.; Tilford, J. Mick
deleteShare
deleteSave
Cost-effectiveness analysis of tucatinib plus trastuzumab versus pertuzumab plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteLiu, Mengmeng; Zhong, Lu; Dong, Mei; Liu, Tong
deleteShare
deleteSave
Net benefits of investing in pulse oximetry and oxygen for childhood pneumonia in high burden countries
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteColbourn, Tim; King, Carina
deleteShare
deleteSave
Comparative cost per responder analysis of ciltacabtagene autoleucel and real-world standard of care therapy in patients with lenalidomide-refractory multiple myeloma
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteHansen, Doris K.; Lu, Xiaoxiao; Castaneda Puglianini, Omar; Zhang, Eileen; Usmani, Saad Z.; Sachdev, Rameet; Perciavalle, Matthew; De Wiest, Denise; Huo, Stephen; Lee, Seina; Qureshi, Zaina P.; Jagannath, Sundar
deleteShare
deleteSave
Impact of early-stage immunotherapy on health and work productivity in the Czech Republic, 2024-2033
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteBlezer, Gittan; Patterson, Karl; Micoch, Tomas; Alahakoon, Jana; Lai, Yizhen; Khurana, Vivek; Aguiar-Ibanez, Raquel
deleteShare
deleteSave
Duration changes and decision-making in DCETTO: evidence from SF-6Dv2
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAmeri, Hosein; Poder, Thomas G.
deleteShare
deleteSave
Climate-related risk and pharmaceutical market dynamics in India and USA: evidence from transfer entropy, BEKK GARCH, and coherence wavelet
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteHarikumar, Yedhu; Muralikrishna, Muthumeenakshi; Muralikrishna, Prakasam; Alola, Andrew Adewale
deleteShare
deleteSave
Prevention, artificial intelligence, and mathematics in health economics: a framework for dynamic value modeling under long-term uncertainty
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteMaas, Lieke; Yaylali, Ayshe; Hiligsmann, Mickael
deleteShare
deleteSave
Medication adherence research: expert perspectives on key HEOR trends for 2026
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAgh, Tamas; Borah, Bijan; Vervloet, Marcia; Hiligsmann, Mickael
deleteShare
deleteSave
Cost-effectiveness analysis of point-of-care A1C tests in the primary care setting of Iran
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteMousavi, Abdoreza; Raadabadi, Mehdi; Darvishi, Ali
deleteShare
deleteSave
Trends in antidepressant utilization, expenditure, and demographic prescribing patterns in Jordan: a retrospective analysis
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteAl Twahya, Safa' F.; Hijazeen, Rima; Almomani, Hamzeh; Alefan, Qais; Alabbadi, Ibrahim
deleteShare
deleteSave
Physicians' preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China
deleteExpert Review of Pharmacoeconomics & Outcomes Research
IF1.5
delete2026-03-01
delete0
PREAI
deleteLi, Yan; Du, Junni; Tian, Chenhui; Ma, Aixia; Tao, Tiantian; Chen, Pingyu
deleteShare
deleteSave